Travere Therapeutics, Inc. · NASDAQ:TVTX
Calvin Sandra sold 21,977 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 14, 2026 · Filed Apr 16, 2026
On Apr 14, 2026, Calvin Sandra (SVP, CHIEF ACCOUNTING OFFICER) sold 21,977 Travere Therapeutics, Inc. shares at US$41.07 for US$903K under a trading plan, leaving 42,353 shares. Filed Apr 16, 2026 (Form 4).
- Sold
- 21,977 shares
- Price
- US$41.07
- Value
- US$903K
- Holding after
- 42,353 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, CHIEF ACCOUNTING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 14, 2026 | Common Stock | Option exercise | 2,500 | US$22.40 | 51,580 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 6,250 | US$8.93 | 57,830 | Direct |
| Apr 14, 2026 | Common Stock | Option exercise | 6,500 | US$20.46 | 64,330 | Direct |
| Apr 14, 2026 | Common Stock | Sale | 21,977 | US$41.07 | 42,353 | Direct |